SC
Steven Cohen (Point72) disclosed new in ESPERION THERAPEUTICS INC NE
Steven Cohen (Point72) filed a 13F change in ESPERION THERAPEUTICS INC NE (29664W105) on 2026-05-15, covering period end 2026-03-31.
Action
New
Capital
$4,628,879 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.